论文信息 - Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study - 字舞流文

Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study

J. Blay | J. Baselga | O. Abdel-Wahab | M. Arcila | M. Lacouture | J. Erinjeri | I. Puzanov | M. Makrutzki | J. Wolf | D. Hyman | N. Raje | A. Lockhart | E. Diamond | G. Ulaner | V. Subbiah | I. Chau | B. Durham | T. Riehl | B. Pitcher | J. Torrisi | F. Martinez-Valle | E. Élez | Jurgen Wolf